tradingkey.logo

Iovance Biotherapeutics Enters Amended Sale Agreement With Jefferies

ReutersAug 22, 2025 10:36 PM

- Iovance Biotherapeutics Inc IOVA.O:

  • IOVANCE BIOTHERAPEUTICS INC - ENTERS AMENDED SALE AGREEMENT WITH JEFFERIES - SEC FILING

  • IOVANCE BIOTHERAPEUTICS INC - MAY SELL UP TO $350 MILLION OF COMMON STOCK - SEC FILING

Source text: [ID:n0001104659-25-081953]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI